7. Jaques 2008 ‐ adverse events at 2 weeks.
Adverse event (possibly or probably related to treatment) |
Mannitol group (n = 38) |
Control group (n = 36) |
||
Not severe | Severe | Not severe | Severe | |
Upper respiratory tract infection | 1 | 0 | 1 | 0 |
Diarrhoea | 0 | 0 | 0 | 1 |
Gastro‐oesophageal reflux | 0 | 0 | 1 | 0 |
Vomiting | 2 | 0 | 0 | 0 |
Chest discomfort | 2 | 0 | 1 | 0 |
Aggravation of CF symptoms | 1 | 0 | 0 | 0 |
Fatigue | 1 | 0 | 0 | 0 |
Anorexia | 1 | 0 | 0 | 0 |
Chest wall pain | 2 | 0 | 0 | 0 |
Dysgeusia | 0 | 0 | 0 | 1 |
Cough | 2 | 2 | 0 | 0 |
Haemoptysis | 2 | 0 | 2 | 0 |
Nasal congestion | 0 | 0 | 1 | 0 |
Pharynolaryngeal pain | 3 | 0 | 0 | 0 |
Respiratory tract congestion | 0 | 0 | 1 | 0 |
Wheeze | 0 | 0 | 1 | 0 |
Total events | 17 | 2 | 8 | 2 |
CF: cystic fibrosis Study definition of "severe": incapacitating, or unable to do usual activities.